YiChang HEC ChangJiang Pharmaceutical Co., Ltd. (HKG:1558)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
13.06
-0.64 (-4.67%)
Jun 6, 2025, 4:08 PM HKT
37.04%
Market Cap 11.49B
Revenue (ttm) 3.96B
Net Income (ttm) 513.69M
Shares Out 879.97M
EPS (ttm) 0.58
PE Ratio 22.37
Forward PE 7.25
Dividend n/a
Ex-Dividend Date n/a
Volume 11,780,800
Average Volume 9,584,548
Open 13.70
Previous Close 13.70
Day's Range 12.90 - 13.72
52-Week Range 7.92 - 15.54
Beta 0.04
RSI 46.21
Earnings Date May 30, 2025

About HKG:1558

YiChang HEC ChangJiang Pharmaceutical Co., Ltd. engages in the development, manufacturing, and sale of pharmaceutical products in the therapeutic areas of anti-virus, endocrine and metabolic, and cardiovascular diseases in the People’s Republic of China. It manufactures and sells active pharmaceutical ingredients and drugs; researches and develops pharmaceutical products and medical devices, as well as biotechnology; and provides marketing and medical consulting services. The company’s product portfolio includes Kewei, Oumeining, Xinhaining, Er... [Read more]

Sector Healthcare
Founded 2001
Employees 4,861
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 1558
Full Company Profile

Financial Performance

In 2024, HKG:1558's revenue was 3.72 billion, a decrease of -40.84% compared to the previous year's 6.29 billion. Earnings were 482.71 million, a decrease of -75.78%.

Financial numbers in CNY Financial Statements

News

There is no news available yet.